Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma	primary central nervous system lymphoma	Recruiting	Phase 1	2026-05-14		NCT06730542

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BeiGene	47
Juan P. Alderuccio, MD	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Miami	Miami	United States	327

Clinical trials